Share on StockTwits

Nu Skin Enterprises (NYSE:NUS) was the target of some unusual options trading activity on Tuesday. Investors bought 2,026 call options on the company, AnalystRatingsNetwork.com reports. This represents an increase of approximately 145% compared to the average volume of 828 call options.

A number of analysts have recently weighed in on NUS shares. Analysts at Zacks downgraded shares of Nu Skin Enterprises from a “neutral” rating to an “underperform” rating in a research note on Tuesday, July 29th. They now have a $60.20 price target on the stock. Separately, analysts at ISI Group downgraded shares of Nu Skin Enterprises from a “neutral” rating to an “underperform” rating in a research note on Friday, July 18th. They now have a $63.00 price target on the stock. Finally, analysts at Bank of America downgraded shares of Nu Skin Enterprises from a “neutral” rating to an “underperform” rating in a research note on Friday, July 18th. They now have a $63.00 price target on the stock. Three research analysts have rated the stock with a sell rating, one has given a hold rating and four have assigned a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and a consensus price target of $93.03.

Nu Skin Enterprises (NYSE:NUS) traded down 0.53% during mid-day trading on Tuesday, hitting $57.92. 1,778,105 shares of the company’s stock traded hands. Nu Skin Enterprises has a 52 week low of $58.00 and a 52 week high of $140.50. The stock has a 50-day moving average of $68.90 and a 200-day moving average of $76.60. The company has a market cap of $3.414 billion and a P/E ratio of 9.57.

Nu Skin Enterprises, Inc is a global direct selling company with operations in 53 markets worldwide. The Company develops and distributes anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands, respectively.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.